After receiving US Food and Drug Administration approval last fall, Dyanavel XR (amphetamine) extended-release tablets are now available in pharmacies for the treatment of attention-deficit/hyperactivity disorder (ADHD) in patients 6 years...
After receiving US Food and Drug Administration approval last fall, Dyanavel XR (amphetamine) extended-release tablets are now available in pharmacies for the treatment of attention-deficit/hyperactivity disorder (ADHD) in patients 6 years...
After receiving US Food and Drug...